Evidence map›Paper›PMID 15481316›Full record

ArticleDigestive diseases and sciences2004

Relationship between fecal calprotectin, intestinal inflammation, and peripheral blood neutrophils in patients with active ulcerative colitis.

Hiroyuki Hanai, Ken Takeuchi, Takayuki Iida, Nobuhito Kashiwagi, Abby R Saniabadi, Isao Matsushita, Yoshihiko Sato, Naoki Kasuga, Toshihiro Nakamura

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Underneath the Gut-Brain Axis in IBD-Evidence of the Non-Obvious.International journal of molecular sciences · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases.JGH open : an open access journal of gastroenterology and hepatology · 2021
    Article
  16. Article
  17. Assessing Severity of Disease in Patients with Ulcerative Colitis.Gastroenterology clinics of North America · 2020
    Review
  18. Calprotectin in inflammatory bowel disease.Clinica chimica acta; international journal of clinical chemistry · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Hiroyuki HanaiDepartment of Endoscopic and Photodynamic Medicine, Hamamatsu University, 1-20-1, Handayama, Hamamatsu 431-3192, Japan. hamai@hamamed.ac.jp
Ken Takeuchi
Takayuki Iida
Nobuhito Kashiwagi
Abby R Saniabadi
Isao Matsushita
Yoshihiko Sato
Naoki Kasuga
Toshihiro Nakamura
Hamamatsu University · JPJIMRO (Japan) · JPKyoto Prefectural University · JPOtsuka (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Active ulcerative colitis (UC) is associated with elevated granulocytes and monocytes/macrophages (GM) which show activation behavior and increased survival time. Further, fecal calprotectin (a stable neutrophil protein) level parallels intestinal inflammation and can predict UC relapse. Since GM are major sources of inflammatory cytokines and chemokines, they are suspected to have roles in the initiation and perpetuation of UC. Our objective was to investigated relationships between peripheral blood (PB) neutrophils, calprotectin, and UC disease activity. Full PB and calprotectin were determined in 69 healthy controls and 31 patients with UC, then 7 randomly selected patients received GM adsorptive apheresis (GMA) with Adacolumn, 10 sessions of 60-min duration each. Patients with UC had higher neutrophil counts (P < 0.001), but lower lymphocyte counts (P < 0.001) compared with controls. Further, fecal calprotectin levels showed a correlation with UC clinical activity index (CAI; P < 0.001) and mucosal inflammation (P < 0.001). Following GMA, there were falls in neutrophils (P < 0.02), CAI (P < 0.02) and calprotectin (P < 0.02). In conclusion, GM appear to contribute to intestinal inflammation and UC activity and reduction of these cells by GMA should benefit patients with active UC. Further, the correlations among calprotectin, UC activities, and PB neutrophils should serve as the basis for preemptive actions to control this disease.

Indexed as

AdolescentAdultCase-Control StudiesCohort StudiesColitis, UlcerativeC-Reactive ProteinEnteritisFecesFemaleHumansInflammation MediatorsLeukocyte CountLeukocyte L1 Antigen ComplexMaleMiddle AgedNeutrophil ActivationC-Reactive ProteinInflammation MediatorsLeukocyte L1 Antigen Complex

Identifiers

PMID15481316
OpenAlexW2006438249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.